Stay updated on Troriluzole for Spinocerebellar Ataxia Clinical Trial
Sign up to get notified when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.

Latest updates to the Troriluzole for Spinocerebellar Ataxia Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.4%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a software release for the study history view. This update does not change the study information or how the history is displayed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision history now shows the latest version as v3.6.6, replacing the previous v3.6.5. This indicates a small update to the page's release notes without changing core study information.SummaryDifference0.1%

- Check77 days agoChange DetectedA new page revision (v3.6.5) has been posted, replacing the previous revision (v3.6.4). This update records a minor maintenance change to the page history rather than a substantive change to study data or descriptions.SummaryDifference0.1%

Stay in the know with updates to Troriluzole for Spinocerebellar Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.